Table 5.

Incidence of adverse reactions in the two groups during the treatment (n, %)

Groups	Nausea and vomiting	Dizziness and headache	Elevated transaminase	Rash	Total incidence
Observation group (n=45)	2 (4.44)	1 (2.22)	0 (0.00)	1 (2.22)	4 (8.89)
Control group (n=44)	2 (4.55)	2 (4.55)	1 (2.27)	1 (2.27)	6 (13.64)
χ 2					0.503
P					0.478